ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Aquestive Therapeutics Inc

Aquestive Therapeutics Inc (AQST)

2,80
0,08
(2,94%)
Geschlossen 02 März 10:00PM
2,78
-0,02
(-0,71%)
Nach Börsenschluss: 1:56AM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
2,78
Gebot
2,70
Fragen
6,94
Volumen
835.495
2,65 Tagesbereich 2,81
2,24 52-Wochen-Bereich 6,23
Marktkapitalisierung
Handelsende
2,72
Handelsbeginn
2,70
Letzter Handelszeitpunkt
Finanzvolumen
US$ 2.282.789
VWAP
2,7323
Durchschnittliches Volumen (3 Mio.)
1.754.313
Ausgegebene Aktien
91.178.193
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-32,44
Gewinn pro Aktie (EPS)
-0,09
Erlöse
50,58M
Nettogewinn
-7,87M

Über Aquestive Therapeutics Inc

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the t... Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Aquestive Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AQST. The last closing price for Aquestive Therapeutics was US$2,72. Over the last year, Aquestive Therapeutics shares have traded in a share price range of US$ 2,24 to US$ 6,23.

Aquestive Therapeutics currently has 91.178.193 shares in issue. The market capitalisation of Aquestive Therapeutics is US$248,00 million. Aquestive Therapeutics has a price to earnings ratio (PE ratio) of -32.44.

AQST Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.34-10.89743589743.123.152.6616913192.8566114CS
4-0.32-10.32258064523.13.632.6621777373.16898269CS
12-1.54-35.64814814814.324.352.6617543133.3285565CS
26-1.81-39.43355119834.595.82.6615163404.1136254CS
52-0.52-15.75757575763.36.232.2418288403.96063467CS
1560.010.3610108303252.776.230.6189574883.10026918CS
260-0.52-15.75757575763.39.4650.6188754913.82218601CS

AQST - Frequently Asked Questions (FAQ)

What is the current Aquestive Therapeutics share price?
The current share price of Aquestive Therapeutics is US$ 2,78
How many Aquestive Therapeutics shares are in issue?
Aquestive Therapeutics has 91.178.193 shares in issue
What is the market cap of Aquestive Therapeutics?
The market capitalisation of Aquestive Therapeutics is USD 248M
What is the 1 year trading range for Aquestive Therapeutics share price?
Aquestive Therapeutics has traded in the range of US$ 2,24 to US$ 6,23 during the past year
What is the PE ratio of Aquestive Therapeutics?
The price to earnings ratio of Aquestive Therapeutics is -32,44
What is the cash to sales ratio of Aquestive Therapeutics?
The cash to sales ratio of Aquestive Therapeutics is 5,05
What is the reporting currency for Aquestive Therapeutics?
Aquestive Therapeutics reports financial results in USD
What is the latest annual turnover for Aquestive Therapeutics?
The latest annual turnover of Aquestive Therapeutics is USD 50,58M
What is the latest annual profit for Aquestive Therapeutics?
The latest annual profit of Aquestive Therapeutics is USD -7,87M
What is the registered address of Aquestive Therapeutics?
The registered address for Aquestive Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Aquestive Therapeutics website address?
The website address for Aquestive Therapeutics is www.aquestive.com
Which industry sector does Aquestive Therapeutics operate in?
Aquestive Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
STAKSTAK Inc
US$ 3,97
(156,13%)
174,23k
ORGOOrganogenesis Holdings Inc
US$ 6,21
(102,28%)
59M
TRNRInteractive Strength Inc
US$ 2,57
(67,97%)
193,57M
PMAXPowell Max Ltd
US$ 0,511
(43,54%)
137,18M
ARBBARB IOT Group Ltd
US$ 0,6635
(38,23%)
59,08M
NVNINVNI Group Ltd
US$ 0,99
(-50,50%)
72,79M
SPGCSacks Parente Golf Inc
US$ 0,2085
(-48,65%)
58,21M
ADGMAdagio Medical Holdings Inc
US$ 0,8081
(-47,53%)
756,76k
PRAXPraxis Precision Medicines Inc
US$ 38,60
(-40,64%)
3,2M
SAGSAG Holdings Ltd
US$ 1,19
(-38,97%)
789,86k
NVDANVIDIA Corporation
US$ 124,92
(3,97%)
389,48M
TRNRInteractive Strength Inc
US$ 2,57
(67,97%)
193,57M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 13,44
(7,78%)
154,46M
PMAXPowell Max Ltd
US$ 0,511
(43,54%)
137,18M
LCIDLucid Group Inc
US$ 2,22
(-0,45%)
136,17M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock